The hTERTα splice variant is a dominant negative inhibitor of telomerase activity

被引:182
作者
Colgin, LM
Wilkinson, C
Englezou, A
Kilian, A
Robinson, MO
Reddel, RR
机构
[1] Childrens Med Res Inst, Westmead, NSW 2145, Australia
[2] CAMBIA, Canberra, ACT 2601, Australia
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源
NEOPLASIA | 2000年 / 2卷 / 05期
关键词
telomerase; telomeres; hTERT; splicing; dominant negative;
D O I
10.1038/sj.neo.7900112
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The telomerase catalytic subunit (hTERT) is an essential component of the holoenzyme complex that adds telomeric repeats to the ends of human chromosomes. Maintenance of telomeres by telomerase or another mechanism is required for cell immortalization, and loss of telomeric DNA has been proposed as a trigger for cellular senescence. Available evidence suggests that regulation of telomerase activity primarily depends on transcriptional control of hTERT. However, several human tissues as well as some normal cell strains have been shown to express low levels of hTERT mRNA even though they lack telomerase activity. We have previously identified six splice variants of hTERT, including a "deletion" variant (hTERT alpha) that is missing conserved residues from the catalytic core of the protein. Several of the deletion variants have been detected in normal and developing human tissues. We now show that hTERT alpha inhibits endogenous telomerase activity, which results in telomere shortening and chromosome end-to-end fusions. Telomerase inhibition induced a senescence-like state in HT1080 cells and apoptosis in a jejunal fibroblast cell line. These results suggest a possible role for hTERT splice variants in the regulation of telomerase activity.
引用
收藏
页码:426 / 432
页数:7
相关论文
共 50 条
  • [21] In vivo regulation of hTERT expression and telomerase activity by androgen
    Guo, CH
    Armbruster, BN
    Price, DT
    Counter, CM
    JOURNAL OF UROLOGY, 2003, 170 (02) : 615 - 618
  • [22] The Major Reverse Transcriptase-Incompetent Splice Variant of the Human Telomerase Protein Inhibits Telomerase Activity but Protects from Apoptosis
    Listerman, Imke
    Sun, Jie
    Gazzaniga, Francesca S.
    Lukas, Jason L.
    Blackburn, Elizabeth H.
    CANCER RESEARCH, 2013, 73 (09) : 2817 - 2828
  • [23] Increase of telomerase activity and hTERT expression in myelodysplastic syndromes
    Briatore, Federica
    Barrera, Giuseppina
    Pizzimenti, Stefania
    Toaldo, Cristina
    Della Casa, Chiara
    Laurora, Stefano
    Pettazzoni, Piergiorgio
    Dianzani, Mario Umberto
    Ferrero, Dario
    CANCER BIOLOGY & THERAPY, 2009, 8 (10) : 883 - 889
  • [24] Gossypol suppresses telomerase activity in human leukemia cells via regulating hTERT
    Moon, Dong-Oh
    Kim, Mun-Ock
    Choi, Yung Hyun
    Lee, Hee Gu
    Kim, Nam Deuk
    Kim, Gi-Young
    FEBS LETTERS, 2008, 582 (23-24) : 3367 - 3373
  • [25] Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase
    Counter, CM
    Meyerson, M
    Eaton, EN
    Ellisen, LW
    Caddle, SD
    Haber, DA
    Weinberg, RA
    ONCOGENE, 1998, 16 (09) : 1217 - 1222
  • [26] Telomerase activity and hTERT protein expression in meningiomas:: An analysis in vivo versus in vitro
    Maes, L.
    Kalala, J. P. O.
    Cornelissen, R.
    De Ridder, L.
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2295 - 2300
  • [27] Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT)
    Ito, Y
    Yoshida, H
    Tomoda, C
    Uruno, T
    Takamura, Y
    Miya, A
    Kobayashi, K
    Matsuzuka, F
    Kuma, K
    Miyauchi, A
    ANTICANCER RESEARCH, 2005, 25 (1B) : 509 - 514
  • [28] The putative tumor suppressor C53 interacts with the human telomerase reverse transcriptase hTERT and regulates telomerase activity
    Zhou, Junzhi
    Xi, Peng
    Zhou, Qi
    Ding, Deqiang
    Cong, Yusheng
    CHINESE SCIENCE BULLETIN, 2014, 59 (19): : 2324 - 2330
  • [29] Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblasts
    Swiggers, SJJ
    Nibbeling, HAJ
    Zeilemaker, A
    Kuijpers, MA
    Mattern, KA
    Zijlmans, JMJM
    EXPERIMENTAL CELL RESEARCH, 2004, 297 (02) : 434 - 443
  • [30] Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells
    Deeb, Dorrah
    Gao, Xiaohua
    Liu, Yongbo
    Pindolia, Kirit
    Gautam, Subhash C.
    ONCOLOGY REPORTS, 2015, 34 (01) : 518 - 524